Nucleoside analogs in the treatment of chronic viral hepatitis efficiency and complications
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (2) , 142-144
- https://doi.org/10.1016/s0168-8278(05)80386-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They InteractPublished by Elsevier ,1993
- A Pilot Study of 2′,3′–Dideoxyinosine for the Treatment of Chronic Hepatitis BHepatology, 1992
- Ribavirin treatment for chronic hepatitis CThe Lancet, 1991
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patientsJournal of Medical Virology, 1989
- Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidineGastroenterology, 1989
- Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patientsHepatology, 1989
- Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBVJournal of Hepatology, 1986
- Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfectionJournal of Hepatology, 1986
- ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT OF INTERFERON IN CHRONIC HEPATITIS BThe Lancet, 1985